Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy

Ann Hematol. 2022 May;101(5):1145-1147. doi: 10.1007/s00277-021-04702-w. Epub 2021 Oct 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Leukemia, Myeloid, Acute* / diagnosis
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / genetics
  • Molecular Diagnostic Techniques
  • Mutation
  • Protein Kinase Inhibitors
  • Sarcoma, Myeloid* / diagnosis
  • Sarcoma, Myeloid* / drug therapy
  • Sarcoma, Myeloid* / genetics
  • fms-Like Tyrosine Kinase 3 / genetics

Substances

  • Protein Kinase Inhibitors
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3